22. 01. 2026
On 19 November 2025, the European Commission (the Commission) presented the first official draft of the legislative package Digital Omnibus[1], the main objective of which is to modernise and streamline the field of European digital law. Together with the core Digital Omnibus package, a separate proposal entitled Digital Omnibus on AI[2] was also published. If …
Read more
16. 01. 2026
On 1 January 2026, a significant part of the act on uniform monthly employer report will come into effect, fundamentally changing the current system of reporting obligations for employers. Although the aim of the new legislation is to unify and simplify reporting to the state, the uniform monthly report will contain a large amount of …
Read more
15. 01. 2026
On 11 December 2025, representatives of the Council of the European Union and the European Parliament reached a political agreement on a new framework for pharmaceutical legislation, the so-called EU Pharmaceutical Package.[1] This represents a comprehensive reform of EU pharmaceutical law and the most extensive revision of the rules governing medicinal products in more than …
Read more
06. 01. 2026
DEAL DONE – C10D PEYTON legal represented ADAX Fond firemního nástupnictví in making its milestone tenth acquisition, which was successfully completed at the end of last year. The ADAX fund’s portfolio was expanded by the engineering company C10D s.r.o., which specializes in custom manufacturing of metal components, primarily for the heavy transport, waste management, maritime …
Read more
30. 12. 2025
The year 2025 brought us many new experiences and opportunities for growth. We are glad that you were part of it and look forward to everything that awaits us in 2026. www.peytonlegal.en 19. 12. 2025
Read more
18. 12. 2025
The European market is increasingly confronted with products whose nature lies at the boundary between medicinal products, food supplements, and foods for special medical purposes, thereby creating significant regulatory uncertainty for both businesses and national authorities. In this context, the judgment of the Court of Justice of the European Union in Case C‑451/24 of 4 …
Read more
22. 01. 2026
On 19 November 2025, the European Commission (the Commission) presented the first official draft of the legislative package Digital Omnibus[1], the main objective of which is to modernise and streamline the field of European digital law. Together with the core Digital Omnibus package, a separate proposal entitled Digital Omnibus on AI[2] was also published. If …
Read more
16. 01. 2026
On 1 January 2026, a significant part of the act on uniform monthly employer report will come into effect, fundamentally changing the current system of reporting obligations for employers. Although the aim of the new legislation is to unify and simplify reporting to the state, the uniform monthly report will contain a large amount of …
Read more
15. 01. 2026
On 11 December 2025, representatives of the Council of the European Union and the European Parliament reached a political agreement on a new framework for pharmaceutical legislation, the so-called EU Pharmaceutical Package.[1] This represents a comprehensive reform of EU pharmaceutical law and the most extensive revision of the rules governing medicinal products in more than …
Read more
06. 01. 2026
DEAL DONE – C10D PEYTON legal represented ADAX Fond firemního nástupnictví in making its milestone tenth acquisition, which was successfully completed at the end of last year. The ADAX fund’s portfolio was expanded by the engineering company C10D s.r.o., which specializes in custom manufacturing of metal components, primarily for the heavy transport, waste management, maritime …
Read more
30. 12. 2025
The year 2025 brought us many new experiences and opportunities for growth. We are glad that you were part of it and look forward to everything that awaits us in 2026. www.peytonlegal.en 19. 12. 2025
Read more
18. 12. 2025
The European market is increasingly confronted with products whose nature lies at the boundary between medicinal products, food supplements, and foods for special medical purposes, thereby creating significant regulatory uncertainty for both businesses and national authorities. In this context, the judgment of the Court of Justice of the European Union in Case C‑451/24 of 4 …
Read more
